ACLS vs BMY · P/E 54, rev $414.1M vs P/E 17, rev $24.46B
Axcelis Technologies Inc (ACLS) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Axcelis Technologies Inc (ACLS) is a semiconductor equipment & materials company listed on NASDAQ.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported ACLS revenue for 2026-06-30 was $414.1M. Net income was $32.5M. ACLS currently screens at market cap $5.39B and trailing P/E 54.5.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
ACLS currently screens at market cap $5.39B and trailing P/E 54.5. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the ACLS and BMY stock pages for the full models.
Not investment advice.